BusinessFDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins Thetis Pharmaceuticals as Senior Medical DirectorBy Nasdaq OMXMay 7, 2018, 4:27 PM UTC
BusinessRegentys Names Dr. John F. Howes Vice President of Clinical and Regulatory AffairsBy Nasdaq OMXJan 9, 2018, 12:31 PM UTC
BusinessThetis Pharmaceuticals Awarded $2.3 Million Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel DiseaseBy Nasdaq OMXNov 16, 2017, 5:35 PM UTC
BusinessRedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn’s DiseaseBy Nasdaq OMXNov 9, 2017, 12:01 PM UTC
BusinessRedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn’s DiseaseBy Nasdaq OMXJul 31, 2017, 12:01 PM UTC
